This Fringe Cannabis Stock Is Gaining Steam — Buy Now
In this month’s edition of my cannabis watchlist, I highlight a company that has shifted from tobacco into the burgeoning pot industry.
Posted by Matthew Clark | Oct 13, 2020 | Investing
In this month’s edition of my cannabis watchlist, I highlight a company that has shifted from tobacco into the burgeoning pot industry.
Posted by Matthew Clark | Oct 11, 2020 | Markets
In this edition of the Money & Markets Week Ahead, I take at look at some companies to watch as earnings season begins again.
Posted by Matthew Clark | Oct 10, 2020 | Investing
Companies are searching for a COVID-19 treatment. We found one vaccine stock to buy now in this week’s episode of The Bull & The Bear.
Posted by Matthew Clark | Oct 9, 2020 | Investing
Cannabis stock HEXO Corp. has partnered with Molson Coors. HEXO stock struggles, but could the Coors venture be its needed shot in the arm?
Posted by Matthew Clark | Oct 8, 2020 | Investing, Podcast
This is the one COVID-19 vaccine stock that you should stay away from at all costs. The deck is stacked against one company in particular.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below